Vaccine-Preventable Viral Diseases

Vaccine-preventable viral diseases are infections caused by viruses for which effective vaccines exist — including measles, mumps, rubella, poliomyelitis, hepatitis A and B, varicella, influenza, rotavirus gastroenteritis, and human papillomavirus-associated disease. This topic describes the group as a category, with attention to highly transmissible agents such as measles whose epidemiology is closely tied to vaccination coverage.

Definition

Vaccine-preventable viral diseases are communicable diseases caused by viruses against which a licensed, effective vaccine is available, considered together as a class within vaccine-preventable diseases.

Scope

The topic surveys viral diseases that routine or targeted immunization can prevent, the features of viral pathogens relevant to vaccine design and transmission, and the epidemiologic patterns observed as coverage changes. It is a reference-level description of the disease group and its population dynamics, not clinical or schedule guidance.

Core questions

• Which viral diseases are preventable by currently available vaccines?
• What features of viral pathogens shape vaccine strategy and transmission?
• How does measles, as a highly transmissible virus, illustrate the dependence of control on coverage?
• How has the burden of viral VPDs changed in the vaccine era?

Key concepts

• Live-attenuated versus inactivated and subunit viral vaccines
• High transmissibility of measles and the resulting high herd-immunity threshold
• Antigenic variation and the influenza vaccine-strain problem
• Mucosal versus systemic immunity (e.g., oral poliovirus vaccine)
• Importation and reseeding in partially immune populations
• Cancer prevention through antiviral vaccination (HPV, hepatitis B)

Mechanisms

Vaccines against viral diseases present viral antigens — as live-attenuated virus, inactivated virus, viral subunits, or nucleic-acid-encoded antigens — to elicit neutralizing antibodies and cellular immunity. Some viral vaccines protect chiefly the individual, while highly transmissible viruses such as measles require very high coverage for population control because their basic reproduction number is large. For agents with antigenic variability, such as influenza, vaccine composition must be updated to match circulating strains. A subset of viral vaccines prevents cancers caused by chronic viral infection, as with hepatitis B and human papillomavirus.

Clinical relevance

Recognizing the viral VPDs and their transmission characteristics supports public-health literacy and evidence appraisal. The strong dependence of measles control on coverage, and the resurgence of cases where coverage falls, characterize the epidemiology of these diseases; this entry is descriptive and is not a basis for individual immunization decisions.

Epidemiology

Several viral VPDs have declined dramatically in the vaccine era; in countries with established programs, reported cases of diseases such as measles, rubella, and polio fell by very large margins relative to the pre-vaccine period. Measles is especially sensitive to coverage gaps: because it is among the most transmissible human pathogens, even modest declines in immunity can permit outbreaks, and importation into partially susceptible populations can reseed transmission.

Evidence & guidelines

The evidence base is largely observational and program-based, including surveillance comparisons across vaccine eras and transmission-dynamic analyses such as Furuse and Oshitani's work on measles in the elimination era. Disease-specific recommendations are set by national immunization advisory bodies and WHO position papers; this entry references them for orientation and does not provide individualized guidance.

History

Vaccines against viral diseases include some of the most consequential in public health: the smallpox vaccine, the inactivated and oral poliovirus vaccines of the 1950s-1960s, and the measles, mumps, and rubella vaccines that followed. Later additions against hepatitis B and human papillomavirus extended vaccination into the prevention of virus-associated cancers, broadening the scope of the viral VPD category.

Key figures

• Stanley Plotkin
• William Moss
• Maurice Hilleman

Seminal works

• furuse-2017
• moss-2011
• plotkin-2018

Frequently asked questions

Why is measles used as the benchmark viral vaccine-preventable disease?

Measles is among the most transmissible human viruses, so its control requires very high vaccination coverage; this makes it a sensitive indicator of immunity gaps and a frequent first sign of falling coverage.

Can a vaccine against a virus also prevent cancer?

Yes. Vaccines against hepatitis B virus and human papillomavirus prevent chronic infections that can lead to liver and cervical and other cancers, so they prevent both the infection and a fraction of the cancers it causes.